NCT06936319

Brief Summary

The present study evaluates whether performing a 14-days counter pressure maneuvers (CPM)-biofeedback training improves the symptomatic burden (primary objective) and secondarily the interference of POTS symptoms with daily activities, fatigue, and health-related quality of life of individuals with POTS compared to best clinical practice non-pharmacological measures. Secondary in-laboratory objectives are to assess the influence of CPM on the supine-to-standing heart rate (HR) and blood pressure (BP) changes as well as on the severity of orthostatic intolerance after performing CPM for two minutes compared to a baseline (intervention-free) active standing test, and to assess the safety and tolerability of CPM-biofeedback training in individuals with POTS. This is a monocentric, proof-of-concept, 1:1 randomized, controlled trial with rater-blinded evaluation of the hemodynamic effect of CPM in 40 individuals suffering from POTS. All study participants will receive detailed counselling on CPM and other behavioral and non-pharmacological measures to combat POTS symptoms in daily life and will be invited to practice them regularly (best clinical practice). Participants randomized to the interventional arm will receive a CPM-biofeedback training session in the autonomic function laboratory at the Department of Neurology of the Innsbruck Medical University to learn four different CPM under continuous HR and BP monitoring. The CPM-biofeedback training will consist of a baseline 2-minutes active standing and the following four different physical maneuver: leg crossing and muscle tensing, heel raises (10 tiptoeing per minute), squatting, unilateral handgrip (20 times a minute). The trial foresees three study visits for both the interventional and the control arm (screening and baseline on-site, as well as a telephone visit 14 days later). For the interventional trial arm, two additional visits are planned (CPM-biofeedback training session in the autonomic function laboratory and a follow-up telephone visit 7 days later). To evaluate the baseline to day-14 change in symptom severity, the Malmö POTS Score (MAPS) total score (primary endpoint) and the MAPS single items, Vanderbilt Orthostatic Symptom Score, Orthostatic Grading Scale, Fatigue Severity Scale and Health-related Quality of Life Questionnaire (EuroQol -EQ-5D-5L ) will be administered.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 2, 2025

Status Verified

March 1, 2025

Enrollment Period

12 months

First QC Date

March 28, 2025

Last Update Submit

April 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Malmö Postural Orthostatic Tachycardia Syndrome symptom score (MAPS)

    Baseline to day-14 change in the total score from 0 to 120. Higher scores means more symptoms and higher symptom severity.

    Baseline to day-14

Secondary Outcomes (14)

  • Severity of orthostatic intolerance (on a 0 - 10 points scale)

    After performing four different counterpressure maneuvers for two minutes each during the biofeedback session, at day 1 +/-3.

  • Absolute heart rate

    At 15, 30, 60, 90 and 120 seconds during four different counterpressure maneuver practiced upon standing , at day 1 +/-3.

  • Absolute systolic and diastolic blood pressure

    At 15, 30, 60, 90 and 120 seconds during counterpressure maneuver practiced upon standing, , at day 1 +/-3.

  • Supine-to-standing change in heart rate

    At 15, 30, 60, 90 and 120 seconds during four different counterpressure maneuvers, at day 1 +/-3.

  • Supine-to-standing change in systolic and diastolic blood pressure

    At 15, 30, 60, 90 and 120 seconds during four different counterpressure maneuvers, at day 1 +/-3.

  • +9 more secondary outcomes

Study Arms (2)

Best clinical practice

ACTIVE COMPARATOR

Counselling on counterpressure maneuvers and other behavioral and non-pharmacological measures to combat POTS symptoms in daily life.

Other: Best clinical practice

Best clinical practice plus CPM-biofeedback training

EXPERIMENTAL

In addition to counselling on CPM and other behavioral and non-pharmacological measures to combat POTS symptoms in daily life, participants undergo a CPM-biofeedback training session in the autonomic function laboratory under continuous HR and BP monitoring.

Behavioral: Best clinical practice plus CPM-biofeedback training

Interventions

The CPM-biofeedback training consists of a baseline 2-minutes active standing and the following four different physical maneuver: leg crossing and muscle tensing, heel raises (10 tiptoeing per minute), squatting, unilateral handgrip (20 times per minute). All exercises will be performed under continuous heart rate and blood pressure monitoring to enable the study participants to gain feedbacks on the effect of the maneuvers on their own biosignals.

Best clinical practice plus CPM-biofeedback training

Recommendations about life-style and behavioural measures to mitigate POTS symptoms in daily life.

Best clinical practice

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • POTS diagnosis
  • to 80 years of age at time of consent
  • stable medication in the seven days prior to the baseline visit
  • able to provide written informed consent

You may not qualify if:

  • participation in other interventional trials
  • pregnant or breastfeeding females
  • on treatment with vasoactive medications including medications for heart rate control
  • acute infections at the time of enrolment or in the two weeks before
  • acute pain
  • surgery in the last three months
  • inability or contraindication for performing hip and knee flexion, hip adduction or squatting
  • inability to stand for at least two minutes
  • Any other cardiological, internal, psychiatric or neurological condition, which may prevent engagement in the sturdy procedures in the judgement of the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Innsbruck

Innsbruck, Tyrol, A-6020, Austria

RECRUITING

MeSH Terms

Conditions

Postural Orthostatic Tachycardia Syndrome

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System Diseases

Central Study Contacts

Alessandra Fanciulli, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 20, 2025

Study Start

January 15, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 2, 2025

Record last verified: 2025-03

Locations